As shown in Figure 8A–8C, kallistatin administration significantly inhibited tumor growth, while this effect was abrogated by co-injection of anti-nucleolin antibody, but not of nonimmune IgG antibody. The gene discussed is NUCLEOLIN; the disease is neoplasm.